Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.

PHASE2UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2002

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

intravenous T900607-sodium

Trial Locations (12)

14642

University of Rochester, Rochester

19104

University of Pennsylvania, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

20037

George Washington University, Washington D.C.

33612

H. Lee Moffitt Cancer Center, Tampa

44106

Ireland Cancer Center, Cleveland

65203

Ellis Fischel Cancer Center, Columbia

75390

University of Texas Southwestern Medical Center, Dallas

87131

University of New Mexico, Albuquerque

92037

Scripps Health Center, La Jolla

92093

University of California San Diego, La Jolla

Unknown

Queen Mary Hospital, Hong Kong

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Tularik

INDUSTRY

NCT00043433 - Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. | Biotech Hunter | Biotech Hunter